Flotation/IPO

DuoLingo brings in $521m IPO
CapitalG sold $36.3m of shares in an upsized offering for the language learning app developer, which saw its shares rise 36% on their first day.
Sema4 secures Nasdaq listing
SoftBank has contributed to a $350m private placement supporting the health screening provider's reverse takeover.
Microvast ties up $3bn reverse takeover
Koch Industries and Oshkosh are backing a $540m private placement supporting the merger between advanced battery maker Microvast and a special purpose acquisition company.
PropertyGuru to build $1.35bn reverse merger
The REA Group-backed real estate marketplace is set to carry out a reverse takeover at a $1.35bn valuation almost two years after it withdrew its attempt to float in Australia.
Outbrain counts up $160m in IPO
The Gruner + Jahr and Susquehanna International Group-backed content recommendation engine developer floated below its range but is slightly up from its IPO price.
Airbus flies into Seraphim
Airbus joined Virgin founder Richard Branson to buy into investment firm Seraphim Space Investment Trust through its initial public offering.
Kaltura cashes $150m in IPO
The Mitsui and Intel-backed video software developer has a market capitalisation of almos $1.5bn following its initial public offering last week.
AbSci nabs $200m in initial public offering
AGC, JSR Life Sciences and Merck & Co all scored exits as the synthetic biology technology developer floated on Nasdaq, whose valuation reportedly stands at nearly $2bn.

Other News

VTex veers to $361m IPO
The SoftBank-backed e-commerce services platform developer listed on the New York Stock Exchange, pricing the shares above their range.
Caribou Biosciences careers on to public markets
The Corteva, Novartis, AbbVie and Heritage Medical Systems-backed cancer therapy developer priced a $304m initial public offering at the top of its range.
Couchbase sits pretty in $200m IPO
Docomo Capital-backed database software provider Couchbase floated above its range in an offering following some $250m in venture funding.
Dook Media reads A-okay for IPO
The Legend Capital-backed paper and digital book publisher has listed on SZSE’s ChiNext market having raised $9.6m.
CloudWalk gets the nod for IPO
The Bohai, Haier and PCI-Suntek-backed facial recognition technology developer has been approved to float on Shanghai’s Star Market in a $574m offering.
IsoPlexis applies itself to IPO filing
Danaher is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.

Editor's Picks

TScan takes in $100m through IPO
The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.
Zomato sets out $1.25bn IPO
The Ant Group, Info Edge and Delivery Hero-backed restaurant listings and food delivery app operator is floating in a dual listing, having secured $562m from anchor investors yesterday.
Rani Therapeutics runs toward public markets
Alphabet, GeneScience, AstraZeneca, Shire, Novartis, Ping An, KPC and Stevanato are in line for exits after the drug delivery technology developer filed to go public.
LinkDoc steps back from IPO plans
The Alibaba-backed medical data software provider has reportedly halted plans for a $211m offering due to regulatory concerns.
test reg

Login

Not yet subscribed?

See your subscription offers here